---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-157311"
form_type: "8-K"
ticker: "KLRS"
cik: "0001754068"
company_name: "Kalaris Therapeutics, Inc."
filed_at: "2024-06-07T23:59:59+00:00"
generated_at: "2026-06-01T05:38:14.998082+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# AlloVir stockholders elect three Class I directors and ratify Deloitte as auditor at 2024 annual meeting

## Summary
- Elected Juan Vera (77.7M for, 4.2M withhold), Morana Jovan-Embiricos (76.2M for, 5.8M withhold), Derek Adams (76.2M for, 5.7M withhold) as Class I directors.
- Ratified Deloitte & Touche as independent auditor for FY2024: 104.2M for, 276K against, 400K abstain.
- Broker non-votes totaled 22,994,115 on each director election; no other matters voted on.
- Meeting held June 6, 2024; record date April 15, 2024 with 114,912,515 shares outstanding.

## SEC filing metadata
- accession: 0001193125-24-157311
- form_type: 8-K
- ticker: KLRS
- cik: 0001754068
- company_name: Kalaris Therapeutics, Inc.
- filed_at: 2024-06-07T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1754068/000119312524157311/0001193125-24-157311-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1754068/000119312524157311/d796921d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-157311
- JSON: https://secwatch.observer/filing/0001193125-24-157311.json
- Plain text: https://secwatch.observer/filing/0001193125-24-157311.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.